Nanostructured boron agents for boron neutron capture therapy: a review of recent patents
Boron neutron capture therapy (BNCT) is a potential radiation therapy modality for cancer, and tumor-targeted stable boron-10 (10B) delivery agents are an important component of BNCT. Currently, two low-molecular-weight boron-containing compounds, sodium mercaptoundecahydro-closo-dodecaborate (BSH)...
Main Authors: | Zhang Xiyin, Lin Yusheng, Hosmane Narayan S., Zhu Yinghuai |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2023-10-01
|
Series: | Medical Review |
Subjects: | |
Online Access: | https://doi.org/10.1515/mr-2023-0013 |
Similar Items
-
Boron Chemistry for Medical Applications
by: Fayaz Ali, et al.
Published: (2020-02-01) -
Synthesis, Molecular Docking, and In Vitro Boron Neutron Capture Therapy Assay of Carboranyl Sinomenine
by: Jianghong Cai, et al.
Published: (2020-10-01) -
A Novel Boron Lipid to Modify Liposomal Surfaces for Boron Neutron Capture Therapy
by: Makoto Shirakawa, et al.
Published: (2021-12-01) -
Boron Neutron Capture Therapy: Current Status and Challenges
by: Song Wang, et al.
Published: (2022-03-01) -
Boron Neutron Capture Therapy: A Review of Clinical Applications
by: Timothy D. Malouff, et al.
Published: (2021-02-01)